Literature DB >> 15981923

Comparison of human and monkey peptide transporters: PEPT1 and PEPT2.

Eric Y Zhang1, Richard M Emerick, Youngeen A Pak, Steven A Wrighton, Kathleen M Hillgren.   

Abstract

Human proton-dependent peptide transporters, PEPT1 and PEPT2, mediate the cellular uptake of di- and tripeptides as well as a variety of drug molecules. Although PEPT1 and PEPT2 have been cloned from many species, there are no data available for monkey, an important pharmacological and preclinical species in drug development. In this study, it was first verified that monkey intestine transports a model dipeptide, Gly-Sar, in a proton-dependent manner (0.30 +/- 0.05 pmol cm(-2) s(-1) at pH 6.0 and 0.10 +/- 0.03 pmol cm(-2) s(-1) at pH 7.4) in the absorptive direction, presumably by monkey PEPT1. RT-PCR and rapid amplification of cDNA ends (RACE) were then used to clone monkey PEPT1 and PEPT2. Monkey PEPT1 (2127 bp and 708 amino acids) was found to be >94 and > 92% identical to human PEPT1 at the cDNA and amino acid level, respectively. Monkey PEPT2 (2190 bp and 729 amino acids) was found to be > 97% identical to human PEPT2 at both the cDNA and amino acid levels. Functional comparison of human and monkey peptide transporters expressed in HeLa cells suggested that functionalities of PEPT1 and PEPT2 were largely conserved in terms of Gly-Sar uptake kinetics and inhibitor specificity (for most tested substrates). Finally, Northern and RT-PCR analyses revealed some differences in tissue mRNA levels of peptide transporters between human and monkey.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15981923     DOI: 10.1021/mp0499712

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  8 in total

1.  Effect of dose escalation on the in vivo oral absorption and disposition of glycylsarcosine in wild-type and Pept1 knockout mice.

Authors:  Dilara Jappar; Yongjun Hu; David E Smith
Journal:  Drug Metab Dispos       Date:  2011-08-31       Impact factor: 3.922

Review 2.  Alternative Splicing: Expanding Diversity in Major ABC and SLC Drug Transporters.

Authors:  Ji Eun Park; Gongmi Ryoo; Wooin Lee
Journal:  AAPS J       Date:  2017-10-02       Impact factor: 4.009

3.  Species Differences in Human and Rodent PEPT2-Mediated Transport of Glycylsarcosine and Cefadroxil in Pichia Pastoris Transformants.

Authors:  Feifeng Song; Yongjun Hu; Huidi Jiang; David E Smith
Journal:  Drug Metab Dispos       Date:  2016-11-11       Impact factor: 3.922

Review 4.  Role and relevance of PEPT2 in drug disposition, dynamics, and toxicity.

Authors:  Mohamed A Kamal; Richard F Keep; David E Smith
Journal:  Drug Metab Pharmacokinet       Date:  2008       Impact factor: 3.614

5.  Mutagenesis and cysteine scanning of transmembrane domain 10 of the human dipeptide transporter.

Authors:  Liya Xu; Ian S Haworth; Ashutosh A Kulkarni; Michael B Bolger; Daryl L Davies
Journal:  Pharm Res       Date:  2009-08-14       Impact factor: 4.200

Review 6.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

7.  In Vitro and Clinical Evaluations of the Drug-Drug Interaction Potential of a Metabotropic Glutamate 2/3 Receptor Agonist Prodrug with Intestinal Peptide Transporter 1.

Authors:  Y Anne Pak; Amanda J Long; William F Annes; Jennifer W Witcher; Mary Pat Knadler; Mosun A Ayan-Oshodi; Malcolm I Mitchell; Phillip Leese; Kathleen M Hillgren
Journal:  Drug Metab Dispos       Date:  2016-11-28       Impact factor: 3.922

8.  Genetic Method for Labeling Electrically Coupled Cells: Application to Retina.

Authors:  Mu Qiao; Joshua R Sanes
Journal:  Front Mol Neurosci       Date:  2016-01-07       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.